- Report
- June 2025
- 222 Pages
Global
From €2219EUR$2,500USD£1,938GBP
- Report
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,162GBP
- Report
- August 2024
- 178 Pages
Global
From €2219EUR$2,500USD£1,938GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,162GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,162GBP
- Report
- June 2025
- 150 Pages
Global
From €2396EUR$2,699USD£2,092GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2476EUR$2,789USD£2,162GBP
- Report
- August 2025
- 50 Pages
Global
From €2353EUR$2,650USD£2,054GBP
- Report
- January 2025
- 179 Pages
Global
From €4434EUR$4,995USD£3,871GBP
- Report
- January 2025
- 178 Pages
Global
From €4434EUR$4,995USD£3,871GBP
- Report
- August 2025
United States
From €1860EUR$2,095USD£1,624GBP
€3542EUR$3,990USD£3,092GBP
- Report
- August 2025
Europe
From €1860EUR$2,095USD£1,624GBP
€3542EUR$3,990USD£3,092GBP
- Report
- August 2025
Middle East
From €1860EUR$2,095USD£1,624GBP
€3542EUR$3,990USD£3,092GBP
- Report
- August 2025
Asia Pacific
From €1860EUR$2,095USD£1,624GBP
€3542EUR$3,990USD£3,092GBP
- Report
- September 2024
- 29 Pages
United States
From €995EUR$1,201USD£899GBP
- Report
- November 2023
- 100 Pages
Global
From €5282EUR$5,950USD£4,611GBP
- Report
- January 2023
- 50 Pages
China
From €2663EUR$3,000USD£2,325GBP
- Report
- February 2023
- 317 Pages
Global
From €4439EUR$5,000USD£3,875GBP
- Report
- August 2024
- 150 Pages
Global
From €3418EUR$3,850USD£2,984GBP
€4306EUR$4,850USD£3,759GBP
- Report
- August 2024
- 150 Pages
Global
From €3418EUR$3,850USD£2,984GBP
€4306EUR$4,850USD£3,759GBP

The Cough and Cold Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat symptoms of the common cold and other respiratory illnesses. These drugs are typically available over-the-counter and are used to reduce the severity of symptoms such as coughing, sneezing, sore throat, and congestion. Common ingredients in these medications include decongestants, antihistamines, expectorants, and pain relievers.
The Cough and Cold Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in this market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, and Sanofi. These companies have a wide range of products available, from traditional medications to more innovative treatments. Additionally, many smaller companies are also active in this market, offering more specialized products. Show Less Read more